AstraZeneca (NASDAQ:AZN) and Merck (NYSE:MRK) said long-term data from a Phase 3 study showed that 87.5% of patients treated with their breast cancer drug Lynparza were still alive six years later, ...
Explore the disproportionate burden of chronic kidney disease in the Black community and the need for empowerment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback